. 2017 Sep 28;19:74. doi: 10.1186/s12968-017-0386-y

Table 2.

Normative ranges for the native ShMOLLI-T1 ranges for the most common myocardial tissue conditions encountered in clinical practice

Native T1 [ms]	Reference myocardium	LGE+ or RWMA+ myocardium
Patients with normal CMR	938 ± 21	–
Cardiac Amyloidosis (AL)	–	1158 ± 75
Cardiac Amyloidosis (ATTR)	1002 ± 63	1061 ± 29
Anderson-Fabry Disease^c	863 ± 23	902 ± 17
Aortic Stenosis	952 ± 20	1019 ± 23^a
Atrial Fibrillation^c	945 ± 25	1010 ± 54
Chronic CAD	951 ± 33	1078 ± 94^a
Dilated Cardiomyopathy	945 ± 27	1038 ± 38^a
Hypertrophic Cardiomyopathy	932 ± 81	1041 ± 86^a
Hypertension	944 ± 24	1022 ± 43^a
Cardiac Iron-Overload^c	795 ± 58	–
Myocarditis (acute)	947 ± 39	1058 ± 74^a
Myocarditis (previous)	941 ± 36	1026 ± 47^a
Musculo-dystrophy	935 ± 23	1006 ± 10^a
Obesity	936 ± 22	1031 ± 28^a
Pheochromocytoma	939 ± 24	1006 ± 20^a
Cardiac Sarcoidosis	934 ± 47	1030 ± 53^a
Takotsubo Cardiomyopathy^b	988 ± 41	1093 ± 64^a

All values are mean ± SD. RWMA regional wall motion abnormalities, LGE late gadolinium enhancement. All other abbreviations are as per Table 1

^ap < 0.001 compared to native T1 of reference myocardium

^bDisease entity in which affected myocardium is characterized by regional wall motion abnormalities (RWMA) only

^c- indicates material from extended analysis period included to address peer-review